These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17575097)

  • 1. Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosis.
    Faulkner L; Altmann DM; Ellmerich S; Huhtaniemi I; Stamp G; Sriskandan S
    Am J Respir Crit Care Med; 2007 Sep; 176(5):473-82. PubMed ID: 17575097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice.
    Sriskandan S; Unnikrishnan M; Krausz T; Dewchand H; Van Noorden S; Cohen J; Altmann DM
    J Infect Dis; 2001 Jul; 184(2):166-73. PubMed ID: 11424013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm.
    Faulkner L; Cooper A; Fantino C; Altmann DM; Sriskandan S
    J Immunol; 2005 Nov; 175(10):6870-7. PubMed ID: 16272345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased surface toll-like receptor 2 expression in superantigen shock.
    Hopkins PA; Pridmore AC; Ellmerich S; Fraser JD; Russell HH; Read RC; Sriskandan S
    Crit Care Med; 2008 Apr; 36(4):1267-76. PubMed ID: 18379254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis.
    Diodato MD; Knöferl MW; Schwacha MG; Bland KI; Chaudry IH
    Cytokine; 2001 May; 14(3):162-9. PubMed ID: 11396994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial superantigens enhance the in vitro proinflammatory response and in vivo lethality of the TLR2 agonist bacterial lipoprotein.
    Kearney DE; Wang W; Redmond HP; Wang JH
    J Immunol; 2011 Nov; 187(10):5363-9. PubMed ID: 22003201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor of activated T cells transcription factor NFATp controls superantigen-induced lethal shock.
    Tsytsykova AV; Goldfeld AE
    J Exp Med; 2000 Aug; 192(4):581-6. PubMed ID: 10952728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock.
    Mountz JD; Baker TJ; Borcherding DR; Bluethmann H; Zhou T; Edwards CK
    J Immunol; 1995 Nov; 155(10):4829-37. PubMed ID: 7594485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
    Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
    Cullen CM; Bonventre PF; Heeg H; Bluethmann H; Mountz JD; Edwards CK
    Pathobiology; 1995; 63(6):293-304. PubMed ID: 8738468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
    Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
    Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.